tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Umer Raffat, 14 are a BUY (82.35%), 3 are a HOLD (17.65%).
Analyst Umer Raffat, currently employed at EVERCORE, carries an average stock price target met ratio of 40% that have a potential upside of 33.98% achieved within 233 days.
Umer Raffat’s has documented 29 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALKS, Alkermes Plc at 24-Oct-2023.
Analyst best performing recommendations are on JAZZ (JAZZ PHARMACEUTICALS PLC).
The best stock recommendation documented was for JAZZ (JAZZ PHARMACEUTICALS PLC) at 2/22/2017. The price target of $160 was fulfilled within 64 days with a profit of $25.05 (18.56%) receiving and performance score of 2.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jul-2021
$14
$0.28 (2.04%)
$16
5 months 6 days ago
(29-Apr-2026)
0/4 (0%)
$0.7 (5.26%)
Sell Since 28-Apr-2026
$14
$0.5 (3.70%)
$5
5 months 7 days ago
(28-Apr-2026)
2/9 (22.22%)
$0.68 (5.11%)
235
Sell Since 27-Jan-2025
$12
$-1.5 (-11.11%)
$14
10 months 24 days ago
(11-Nov-2025)
2/8 (25%)
$4.52 (60.43%)
174
Hold Since 03-Jun-2021
$9
$-4.5 (-33.33%)
$10
10 months 24 days ago
(11-Nov-2025)
5/13 (38.46%)
$1.52 (20.32%)
112
Hold Since 07-Oct-2024
$15
$1.5 (11.11%)
$27
1 years 5 months 13 days ago
(22-Apr-2025)
0/2 (0%)
$3.87 (34.77%)
What Year was the first public recommendation made by Umer Raffat?
